Invention Grant
- Patent Title: One component fibrin glue comprising zymogens
-
Application No.: US15629392Application Date: 2017-06-21
-
Publication No.: US10555991B2Publication Date: 2020-02-11
- Inventor: Yair Pilpel , Ashley Deanglis , Yuri Zherdev , Sivan Doron , Anne Gorman , Israel Nur
- Applicant: Omrix Biopharmaceuticals Ltd. , Ethicon, Inc.
- Applicant Address: IL Rehovot US NJ Somerville
- Assignee: Omrix Biopharmaceuticals Ltd.,Ethicon, Inc.
- Current Assignee: Omrix Biopharmaceuticals Ltd.,Ethicon, Inc.
- Current Assignee Address: IL Rehovot US NJ Somerville
- Agent David R. Crichton
- Priority: IL230150 20131224
- Main IPC: A61K38/36
- IPC: A61K38/36 ; A61L24/10 ; A61K38/48 ; A61K38/17 ; A61K31/194 ; A61K31/198 ; A61K33/14 ; A61L24/00
Abstract:
Provided herein is a single component sealant formulation (e.g. in a liquid form), methods for its preparation, and use. The formulation includes fibrinogen; vitamin K-dependent clotting zymogens comprising at least Factor II (FII) and Factor X (FX).
Public/Granted literature
- US20170290949A1 ONE COMPONENT FIBRIN GLUE COMPRISING ZYMOGENS Public/Granted day:2017-10-12
Information query
IPC分类:
